Thomas Grant secures $2.18 million grant to pioneer protein-studying tool that could lead to new and personalized medicine.

Karuna Therapeutics and Bristol Myers Squibb are winners of the 2025 Gizmodo Science Fair for their research and development ...

Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and ...

For decades in life sciences, pharmacovigilance (PV)—a critical reinforcer of drug safety—has been a reactive function. Its ...

M&A transactions improve economic efficiencies and are an essential driver of U.S. economic growth. Capricious enforcement of ...

In its latest, proposed incarnation, Ruse Treatment representatives outlined plans for a high-end care destination comparable ...

A leading neurologist involved in development of Alterity's lead compound ATH434 believes it could be a game changer for sufferers of MSA.

A hopeful report about a potential blockbuster drug currently in development and news of an expansion of manufacturing ...

Tuberculosis and Malaria are two major infectious diseases caused by species belonging to Mycobacterium and Plasmodium, ...

AbCellera Biologics Inc. (NASDAQ: ABCL) is one of the best healthcare penny stocks to buy now. On September 10, the company ...

With weight-loss drugs such as Wegovy in short supply, less-than-reputable pharmacies have sold knock-off compounded drugs in their place. That practice needs to end.

While the current freight market has excess capacity, actions taken now are setting the stage for a severe driver shortage.